Commonwealth Retirement Investments’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,849
Closed -$401K 104
2024
Q4
$401K Buy
+4,849
New +$417K 0.17% 84
2024
Q1
Sell
-20,462
Closed -$1.56M 87
2023
Q4
$1.56M Buy
+20,462
New +$1.46M 0.83% 39

Other funds holding PJP

Commonwealth Retirement Investments's PJP Position: Q1 2025 in Review

Commonwealth Retirement Investments sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2025, closing a stake of 4,849 shares — an estimated $401K sold.

Commonwealth Retirement Investments first reported a position in PJP in Q4 2023 and held it in 2 quarters. The position peaked at $1.56M in Q4 2023. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2025.

  • Commonwealth Retirement Investments reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
  • Commonwealth Retirement Investments sold 4,849 Invesco Pharmaceuticals ETF shares in Q1 2025, an estimated $401K.
  • Commonwealth Retirement Investments first reported a position in Invesco Pharmaceuticals ETF in Q4 2023 and held it in 2 quarters.
  • Commonwealth Retirement Investments's Invesco Pharmaceuticals ETF position peaked at $1.56M in Q4 2023.
  • 96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2025.

Based on Commonwealth Retirement Investments's 13F filing for Q1 2025, filed 9 May 2025.